| 000 | 01726 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516005513.0 | ||
| 264 | 0 | _c20120822 | |
| 008 | 201208s 0 0 eng d | ||
| 022 | _a1559-131X | ||
| 024 | 7 |
_a10.1007/s12032-010-9709-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aXia, Liang-Ping | |
| 245 | 0 | 0 |
_aShort-term outcomes of cetuximab combined with standard chemotherapy as first line setting for Chinese patients with non-small cell lung cancer: a report of 12 cases. _h[electronic resource] |
| 260 |
_bMedical oncology (Northwood, London, England) _cDec 2011 |
||
| 300 |
_aS570-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 | _aAsian People |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 | _aCetuximab |
| 650 | 0 | 4 |
_aExanthema _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aQiu, Hui-Juan | |
| 700 | 1 | _aChen, Xu-Xian | |
| 700 | 1 | _aHu, Pi-Li | |
| 700 | 1 | _aGuo, Gui-Fang | |
| 700 | 1 | _aWang, Fang | |
| 700 | 1 | _aZhou, Fei-Fei | |
| 700 | 1 | _aHe, Wen-Zhuo | |
| 700 | 1 | _aZhang, Bei | |
| 700 | 1 | _aZhang, Li | |
| 773 | 0 |
_tMedical oncology (Northwood, London, England) _gvol. 28 Suppl 1 _gp. S570-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12032-010-9709-7 _zAvailable from publisher's website |
| 999 |
_c20269887 _d20269887 |
||